(-0.46%) 5 048.42 points
(-0.98%) 38 086 points
(-0.64%) 15 612 points
(0.24%) $83.77
(-2.26%) $1.601
(0.11%) $2 345.10
(0.41%) $27.47
(0.73%) $927.20
(-0.27%) $0.932
(-0.20%) $10.96
(-0.39%) $0.799
(-0.17%) $92.17
Live Chart Being Loaded With Signals
Profarma Distribuidora de Produtos Farmacêuticos S.A., together with its subsidiaries, engages in the distribution and retail sale of pharmaceutical and hospital products in Brazil...
Stats | |
---|---|
Today's Volume | 310 800 |
Average Volume | 254 893 |
Market Cap | 729.54M |
EPS | BRL0 ( 2024-03-06 ) |
Next earnings date | ( BRL0 ) 2024-05-08 |
Last Dividend | BRL0 ( N/A ) |
Next Dividend | BRL0 ( N/A ) |
P/E | 10.44 |
ATR14 | BRL0.00900 (0.15%) |
Volume Correlation
Profarma Distribuidora de Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Profarma Distribuidora de Correlation - Currency/Commodity
Profarma Distribuidora de Financials
Annual | 2023 |
Revenue: | BRL8.66B |
Gross Profit: | BRL1.29B (14.92 %) |
EPS: | BRL0.570 |
Q4 | 2023 |
Revenue: | BRL2.21B |
Gross Profit: | BRL439.54M (19.92 %) |
EPS: | BRL0.230 |
Q3 | 2023 |
Revenue: | BRL2.30B |
Gross Profit: | BRL337.79M (14.70 %) |
EPS: | BRL0.260 |
Q2 | 2023 |
Revenue: | BRL2.13B |
Gross Profit: | BRL336.39M (15.76 %) |
EPS: | BRL0.120 |
Financial Reports:
No articles found.
Profarma Distribuidora de
Profarma Distribuidora de Produtos Farmacêuticos S.A., together with its subsidiaries, engages in the distribution and retail sale of pharmaceutical and hospital products in Brazil. The company operates through Distribution, and Retail segments. It provides branded medicines, generic drugs, and over-the-counter (OTC) medicines; personal hygiene, beauty, and cosmetic products, such as shampoos, conditioners, treatment creams and hair dyes, diapers and children's products, soaps , deodorants, oral care products, sunscreens, male products, cosmetics, makeup and skin products, and others; and hospital products, including injectable and infusion drugs for oncology, endocrinology, rheumatology, infectology, hematology, and other specialties. The company also offers vaccines for influenza, HPV, meningitis, hepatitis, chickenpox, dengue, and other diseases; special medicines intended for the treatment of rare and complex diseases; exclusive hygiene and beauty products, vitamins, and workshops products under the Nº21, GOnutri, and Bem Básico brands; and convenience products, including food products, pressure gauges, scales, and related products. In addition, it provides complementary services, such as promotional and logistical support, implementation of promotional campaigns, product recall, development of customized projects to offer laboratories solutions, and management of clinical procedures. As of December 31, 2019, the company operated eleven distribution centers located in the states of Alagoas, Bahia, Espírito Santo, Goiás, Minas Gerais, Paraíba, Paraná, Pernambuco, Rio Grande do Sul, Rio de Janeiro, and São Paulo, as well as approximately 196 stores in the states of Rio de Janeiro, Goiás, Tocantins, Mato Grosso, and Distrito Federal under the Drogarias Tamoio, Drogasmil, Farmalife, and Rede Rosário brands. The company was founded in 1961 and is headquartered in Rio de Janeiro, Brazil.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators